drugset / Trial / NCT02111252
A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects
NaSingle-groupOpen-labelTreatment
Summary
This clinical trial is a phase 1/2 study of a single intramuscular injection of TAK-850 in healthy Japanese adult participants
Timeline
- Start
- 2014-03
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-850 | Vaccine | 15 ug | Intramuscular |
| Subject | TAK-850 | Vaccine | 0.5 ml | Intramuscular |